Transcriptional control of the tumor-and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? S Kaluz, M Kaluzová, SY Liao, M Lerman, EJ Stanbridge Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (2), 162-172, 2009 | 309 | 2009 |
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex J Fan, C Shan, HB Kang, S Elf, J Xie, M Tucker, TL Gu, M Aguiar, ... Molecular cell 53 (4), 534-548, 2014 | 292 | 2014 |
Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element S Kaluz, M Kaluzová, EJ Stanbridge Clinica Chimica Acta 395 (1-2), 6-13, 2008 | 233 | 2008 |
Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: a role for … S Kaluz, M Kaluzová, A Chrastina, PL Olive, S Pastoreková, J Pastorek, ... Cancer research 62 (15), 4469-4477, 2002 | 186 | 2002 |
Hypoxia inducible factor pathway inhibitors as anticancer therapeutics SK Burroughs, S Kaluz, D Wang, K Wang, EG Van Meir, B Wang Future medicinal chemistry 5 (5), 553-572, 2013 | 168 | 2013 |
Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1α C-terminal activation domain S Kaluz, M Kaluzová, EJ Stanbridge Molecular and cellular biology 26 (15), 5895-5907, 2006 | 146 | 2006 |
DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1α in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX M Kaluzová, S Kaluz, MI Lerman, EJ Stanbridge Molecular and cellular biology 24 (13), 5757-5766, 2004 | 117 | 2004 |
Genetic Interaction between Distinct Dobrava Hantavirus Subtypes in Apodemus agrarius and A. flavicollis in Nature B Klempa, HA Schmidt, R Ulrich, S Kaluz, M Labuda, H Meisel, B Hjelle, ... Journal of virology 77 (1), 804-809, 2003 | 116 | 2003 |
Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer S Kaluz, M Kaluzová, EJ Stanbridge Cancer research 63 (5), 917-922, 2003 | 105 | 2003 |
A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1 SM Cork, B Kaur, NS Devi, L Cooper, JH Saltz, EM Sandberg, S Kaluz, ... Oncogene 31 (50), 5144-5152, 2012 | 93 | 2012 |
Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP S Yin, S Kaluz, NS Devi, AA Jabbar, RG de Noronha, J Mun, Z Zhang, ... Clinical Cancer Research 18 (24), 6623-6633, 2012 | 92 | 2012 |
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines N Shafee, S Kaluz, N Ru, EJ Stanbridge Cancer letters 282 (1), 109-115, 2009 | 86 | 2009 |
Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster K Kölble, J Lu, SE Mole, S Kaluz, KBM Reid Genomics 17 (2), 294-298, 1993 | 77 | 1993 |
Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement KF Nolan, S Kaluz, KBM Reid, MP Dierich, W Schwaeble European journal of immunology 21 (3), 771-776, 1991 | 77 | 1991 |
Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX: identification and characterization of a proximal silencer element S Kaluz, M Kaluzová, R Opavský, S Pastoreková, A Gibadulinová, ... Journal of Biological Chemistry 274 (46), 32588-32595, 1999 | 76 | 1999 |
Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors M Kaluzova, S PASTOREKOVÁ, E SVASTOVÁ, J PASTOREK, ... Biochemical Journal 359 (3), 669-677, 2001 | 67 | 2001 |
Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway SR Mooring, H Jin, NS Devi, AA Jabbar, S Kaluz, Y Liu, EG Van Meir, ... Journal of medicinal chemistry 54 (24), 8471-8489, 2011 | 58 | 2011 |
Characterization of the human properdin gene KF Nolan, S Kaluz, JMG Higgins, D Goundis, KBM Reid Biochemical journal 287 (1), 291-297, 1992 | 55 | 1992 |
Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma L Dong, S You, Q Zhang, S Osuka, NS Devi, S Kaluz, JH Ferguson, ... Clinical Cancer Research 25 (7), 2206-2218, 2019 | 53 | 2019 |
Directional cloning of PCR products using exonuclease III. S Kaluz, K Kölble, KB Reid Nucleic acids research 20 (16), 4369, 1992 | 47 | 1992 |